HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, M Articles by Zhao, M H Search for Related Content PubMed PubMed Citation Articles by Chen, M Articles by Zhao, M H

Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre

Renal Division and Institute of Nephrology, Peking University First Hospital, Beijing, PR China

Correspondence to:
Correspondence to:
Dr M H Zhao
Renal Division and Institute of Nephrology, Peking University First Hospital, Beijing 100034, PR China; mhzhao{at}bjmu.edu.cn

Background: Antineutrophil cytoplasmic autoantibodies (ANCA) are serological markers of ANCA associated systemic vasculitides (AASV), which is one of the most common multisystem autoimmune diseases. Features of Chinese patients with AASV have not been fully investigated.

Objective: To analyse the clinical and pathological characteristics of Chinese patients with AASV.

Methods: 426 Chinese patients with AASV diagnosed in the past eight years were retrospectively studied and their clinical and pathological data were analysed.

Results: Of the 426 patients, 87 (20.4%) were Wegener’s granulomatosis, 337 (79.1%) were microscopic polyangiitis and two (0.5%) were Churg-Strauss syndrome. Only 201 of 426 (47.2%) patients were diagnosed within three months. Clinically, the patients had multisystem involvement. Altogether 371 of 426 (87.1%) had kidney involvement and 260 of 426 (61.0%) had lung involvement. The prevalences of renal involvement and fatigue were significantly higher in patients with MPO-ANCA than that in patients with PR3-ANCA; the prevalences of ophthalmic, nasal involvement, rash, and arthragia were significantly higher in patients with PR3-ANCA than those in patients with MPO-ANCA. The one and five year death rates were 13.1% and 22.4%, respectively. The percentage of patients progressing to end stage renal disease at one and five years was 15.9% and 27.1%, respectively.

Conclusions: AASV is not a rare autoimmune disease in Chinese people. Kidney and lung were the most vulnerable organs. For patients with multiorgan damage, an ANCA test should be performed to make an early diagnosis and to start treatment in time.

Abbreviations: ANCA, antinuetrophil cytoplasmic autoantibodies; AASV, ANCA associated systemic vasculitides; WG, Wegener’s granulomatosis; MPA, microscopic polyangiitis; CSS, Churg-Strauss syndrome; ACR, American College of Rheumatology; ANA, antinuclear antibodies; ESR, erythrocyte sedimentation rate; MMF, mycophenolate mofetil; MPO, myeloperoxidase

Keywords: ANCA; vasculitide

This article has been cited by other articles:

				R. A. Watts, D. G. I. Scott, D. R. W. Jayne, T. Ito-Ihara, E. Muso, S. Fujimoto, Y. Harabuchi, S. Kobayashi, K. Suzuki, and H. Hashimoto Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype? Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3928 - 3931. [Abstract] [Full Text] [PDF]

				W. Hu, C. Liu, H. Xie, H. Chen, Z. Liu, and L. Li Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1307 - 1312. [Abstract] [Full Text] [PDF]

				M. Chen, F. Yu, S.-X. Wang, W.-Z. Zou, Y. Zhang, M.-H. Zhao, and H.-Y. Wang Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 139 - 145. [Abstract] [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer Ann Rheum Dis, September 1, 2006; 65(9): 1174 - 1174. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer Br. J. Sports Med., August 1, 2006; 40(8): 695 - 695. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer Sex Transm Inf, August 1, 2006; 82(4): 329 - 329. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer J. Clin. Pathol., August 1, 2006; 59(8): 861 - 861. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer Inj. Prev., August 1, 2006; 12(4): 265 - 265. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer Br. J. Sports Med., July 1, 2006; 40(7): 636 - 636. [Full Text] [PDF]

				More endoscopists improve outcome for upper GI cancer J. Clin. Pathol., July 1, 2006; 59(7): 680 - 680. [Full Text] [PDF]